HIIT Versus MICT in COPD: Effects on Oxygenation, Pulmonary Function, and Strength

NCT ID: NCT07109687

Last Updated: 2025-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-01

Study Completion Date

2027-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic Obstructive Pulmonary Disease (COPD) is a progressive condition marked by airflow limitation and chronic inflammation, leading to reduced exercise capacity, peripheral muscle dysfunction, and dyspnea. High-Intensity Interval Training (HIIT) may offer a promising alternative for patients with low exercise tolerance; however, evidence on its effectiveness remains limited.

This study aims to compare the effects of HIIT and Moderate-Intensity Continuous Training (MICT) on muscle oxygenation, pulmonary function, exercise capacity, and peripheral muscle strength in individuals with COPD. Participants will undergo an 8-week exercise program, twice weekly. HIIT will consist of 1-minute intervals at 90% and 30-40% of peak workload, while MICT will involve continuous cycling at 65% of peak workload. Outcomes will be assessed at baseline, week 4, and week 8. Data will be analyzed using SPSS. This study seeks to determine the more effective training modality to optimize COPD rehabilitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease (COPD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

HIIT or MICT will be applied in patients with COPD groups.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors
Statistical Analyzer will be masked.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

standard aerobic exercise will apply in moderate intensity continuous training.

Group Type ACTIVE_COMPARATOR

MICT

Intervention Type OTHER

Moderate intensity continous exercise

interval exercise group

Group Type EXPERIMENTAL

HIIT GROUP

Intervention Type OTHER

Participants will perform a 31-minute protocol on a cycle ergometer consisting of 1-minute high-intensity intervals at 90% of peak workload (W peak) and low-intensity intervals at 30-40% of W peak, twice a week for 8 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HIIT GROUP

Participants will perform a 31-minute protocol on a cycle ergometer consisting of 1-minute high-intensity intervals at 90% of peak workload (W peak) and low-intensity intervals at 30-40% of W peak, twice a week for 8 weeks.

Intervention Type OTHER

MICT

Moderate intensity continous exercise

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with Chronic Obstructive Pulmonary Disease (COPD),
* GOLD stage 2, 3, or 4,
* Willing to participate in the study,
* Aged between 40 and 80 years,
* Clinically stable (no significant deterioration in the current medical condition, no recent initiation of a new treatment, and no complications requiring hospitalization).

Exclusion Criteria

* Presence of visual, auditory, vestibular, cognitive, or neurological impairments that may affect balance,
* Any orthopedic, neurological, or cardiac conditions that may interfere with study participation or exercise,
* Presence of serious chronic diseases such as congestive heart failure, coronary artery disease, or chronic renal failure,
* Conditions that may cause physical limitations (e.g., limb amputation, significant musculoskeletal disorders, or postural abnormalities such as kyphosis or lordosis).
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Antalya Bilim University

OTHER

Sponsor Role collaborator

Hacettepe University

OTHER

Sponsor Role collaborator

Aynur Demirel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aynur Demirel

PT, PhD, Assoc. Prof.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fulsen Bozkus, MD., Prof.

Role: STUDY_DIRECTOR

Sağlık Bilimleri University Antalya Health Application and Research Center

Aynur Demirel, PT, PhD, Assoc. Prof.

Role: PRINCIPAL_INVESTIGATOR

Hacettepe University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Aynur Demirel, PT, PhD, Assoc. Prof.

Role: CONTACT

+903051576168

Irem Suzen, PT MsC

Role: CONTACT

+905393260706

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BSV-000021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.